A randomized, double-blind placebo-controlled single-to multiple-dose escalation study to investigate the safety, tolerability and pharmacokinetics of RSV604 intravenous formulation in healthy subjects.

Trial Profile

A randomized, double-blind placebo-controlled single-to multiple-dose escalation study to investigate the safety, tolerability and pharmacokinetics of RSV604 intravenous formulation in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Nov 2011

At a glance

  • Drugs RSV 604 (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Nov 2011 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 21 Jun 2007 Status change from in progress to completed
    • 01 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top